Table 8.
GeneGo mapped pathways for CORE ‘C1N65’ from the NCI60 for η=0.65
| No | Pathway maps | p-value |
|---|---|---|
| 1 | Development_miRNA-dependent inhibition of EMT | 3.38E–12 |
| 2 | Cytoskeleton remodelling_Keratin filaments | 2.41E–11 |
| 3 | Cell adhesion_Endothelial cell contacts by junctional mechanisms | 1.03E–07 |
| 4 | Cell adhesion_Tight junctions | 8.05E–07 |
| 5 | Cell adhesion_Gap junctions | 1.54E–04 |
| 6 | Development_Neural stem cell lineage commitment (schema) | 3.92E–04 |
| 7 | Cell cycle_Role of 14–3–3 proteins in cell cycle regulation | 1.03E–03 |
| 8 | Hypoxia–induced EMT in cancer and fibrosis | 2.90E–03 |
| 9 | LRRK2 in neurons in Parkinson’s disease | 3.39E–03 |
| 10 | G–protein signaling_RhoA regulation pathway | 3.69E–03 |
| 11 | Development_TGF– β–dependent induction of EMT via SMADs | 4.01E–03 |
| 14 | Development_TGF– β–dependent induction of EMT via MAPK | 9.18E–03 |
| 20 | Development_Regulation of EMT | 2.11E–02 |